Cord stem cells tested for Life-Threatening lung failure
NCT ID NCT07413978
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests whether stem cells from umbilical cords are safe for people with moderate to severe acute respiratory distress syndrome (ARDS), a serious lung condition. About 36 adults will receive an injection of these cells to find the safest dose and check for side effects. The goal is to see if this approach can help control the disease and improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhongnan Hospital of Wuhan University
RECRUITINGWuhan, Hubei, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Lung-Opening maneuver change a key injury marker in ARDS?
- Could simply sitting up ease breathing in severe lung failure?
- Could lung fluid proteins reveal a new way to track severe lung injury?
- Could a spirometer test guide breathing support in respiratory failure?
- Which ventilator setting saves more lungs? a Head-to-Head test
- Can a single antibody turn down the immune storm in ARDS?